Literature DB >> 21209251

Macrophages in renal disease.

Yiping Wang1, David C H Harris.   

Abstract

Macrophages have heterogeneous phenotypes as they exercise their twofold role in the development and recovery of renal diseases. Some subpopulations of macrophages (M1) have a pathogenic function in renal inflammation, making them a logical target for elimination. Alternatively, M2 macrophage subpopulations resolve inflammation and repair injury, making them a potential therapeutic tool against renal injury. Here, we summarize recent findings regarding macrophage plasticity, and the various strategies for targeting or utilizing macrophages to treat renal disease. We highlight, in particular, the potential of renoprotective M2 macrophages to resolve inflammation and repair the kidney.

Entities:  

Mesh:

Year:  2011        PMID: 21209251     DOI: 10.1681/ASN.2010030269

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  97 in total

Review 1.  The renal mononuclear phagocytic system.

Authors:  Peter J Nelson; Andrew J Rees; Matthew D Griffin; Jeremy Hughes; Christian Kurts; Jeremy Duffield
Journal:  J Am Soc Nephrol       Date:  2011-12-01       Impact factor: 10.121

Review 2.  Cellular and molecular mechanisms of renal fibrosis.

Authors:  Youhua Liu
Journal:  Nat Rev Nephrol       Date:  2011-10-18       Impact factor: 28.314

3.  Inflammatory and injury signals released from the post-stenotic human kidney.

Authors:  Alfonso Eirin; Monika L Gloviczki; Hui Tang; Mario Gössl; Kyra L Jordan; John R Woollard; Amir Lerman; Joseph P Grande; Stephen C Textor; Lilach O Lerman
Journal:  Eur Heart J       Date:  2012-07-06       Impact factor: 29.983

4.  Macrophage-derived TGF-β in renal fibrosis: not a macro-impact after all.

Authors:  Roderick J Tan; Youhua Liu
Journal:  Am J Physiol Renal Physiol       Date:  2013-07-03

5.  Isolation of murine peritoneal macrophages to carry out gene expression analysis upon Toll-like receptors stimulation.

Authors:  Antonio Layoun; Macha Samba; Manuela M Santos
Journal:  J Vis Exp       Date:  2015-04-29       Impact factor: 1.355

Review 6.  Dendritic Cells and Macrophages: Sentinels in the Kidney.

Authors:  Christina K Weisheit; Daniel R Engel; Christian Kurts
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-07       Impact factor: 8.237

7.  Cannabinoid receptor 1 is a major mediator of renal fibrosis.

Authors:  Lola Lecru; Christophe Desterke; Stanislas Grassin-Delyle; Christos Chatziantoniou; Sophie Vandermeersch; Aurore Devocelle; Amelia Vernochet; Ninoslav Ivanovski; Catherine Ledent; Sophie Ferlicot; Meriem Dalia; Myriam Saïd; Séverine Beaudreuil; Bernard Charpentier; Aimé Vazquez; Julien Giron-Michel; Bruno Azzarone; Antoine Durrbach; Hélène François
Journal:  Kidney Int       Date:  2015-03-11       Impact factor: 10.612

8.  TGF expression and macrophage accumulation in atherosclerotic renal artery stenosis.

Authors:  Monika L Gloviczki; Mira T Keddis; Vesna D Garovic; Hanna Friedman; Sandra Herrmann; Michael A McKusick; Sanjay Misra; Joseph P Grande; Lilach O Lerman; Stephen C Textor
Journal:  Clin J Am Soc Nephrol       Date:  2012-12-20       Impact factor: 8.237

9.  Epithelial cell TGFβ signaling induces acute tubular injury and interstitial inflammation.

Authors:  Madeleine E Gentle; Shaolin Shi; Ilse Daehn; Taoran Zhang; Haiying Qi; Liping Yu; Vivette D D'Agati; Detlef O Schlondorff; Erwin P Bottinger
Journal:  J Am Soc Nephrol       Date:  2013-03-28       Impact factor: 10.121

Review 10.  Soluble biglycan as a biomarker of inflammatory renal diseases.

Authors:  Louise Tzung-Harn Hsieh; Madalina-Viviana Nastase; Jinyang Zeng-Brouwers; Renato V Iozzo; Liliana Schaefer
Journal:  Int J Biochem Cell Biol       Date:  2014-08-01       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.